Tolerability of pemetrexed versus placebo as a maintenance therapy in advanced non-small cell lung cancer: Evidence from a large randomized study

8060 Background: Cytotoxic chemotherapy seeks to reduce or stabilize tumor burden in advanced non-small cell lung cancer (NSCLC). Administration, however, is limited by cumulative toxicity or dimin...